Key facts
- EndoQuest Robotics’s last known valuation is $319.0M (Jul 2025).
- It has raised $204.2M across 1 recorded rounds; the latest was Early Stage VC ($30.7M) in May 2025.
- Notable investors include CE-Ventures, Mithril Capital Management, Puma Venture Capital, Crescent Enterprises Invests, Frederic Moll — 7 tracked in total.
- EndoQuest Robotics has filed 1 Form D with the SEC, most recently Aug 2025 ($30.7M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for EndoQuest Robotics
Funding rounds
1 roundsAbout EndoQuest Robotics
Developer of flexible robotic devices designed to perform procedures in the body using the natural lumens and operating scar-free. The company designs and develops next-generation microsurgical robotic devices used to perform procedures in delicate body regions inaccessible to current technology, enabling surgeons to provide cost-effective and innovative treatments to patients.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2017
- Employees
- 69
- Website
- endoquestrobotics.com/
- Ownership
- Privately Held (backing)
EndoQuest Robotics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EndoQuest Robotics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EndoQuest Robotics in its N-PORT filings yet. We sweep new filings monthly.